As modern advances in diagnosis and treatment ever increase the average life expectancy, the prevalence of age-related disorders also increases as a consequence. For example, between 2015 and 2050, the proportion of the world’s population over 60 years will nearly double from 12% to 22%, at a rate observed faster at any other point in history. In the UK alone there are currently around 900,000 people with dementia, which is projected to rise to 1.6 million by 2040.
Understanding the causes, both biological and environmental, of such neurodegenerative disorders is a key theme at CINN. We take a multidisciplinary approach to this subject by linking together cognitive neuroscience, physiology and cell biology, and nutritional science. By measuring multiple constructs in this manner, we can develop a greater picture with understanding the effects these conditions have, not only with respect to the brain, but the entire body. Furthermore, by understanding the factors influencing dementia, and how this is presented before the onset of the disease through biomarkers, we can identify those at risk at an earlier stage and subsequent improve their prognosis.
CINN is a member of UKAgeNet, a consortium bringing together more than 60 leading national centres, institutes, and networks at the forefront of ageing research, launched at Westminster on 20th November 2023.
We are proud to contribute to the network’s aims, working towards a healthier, happier later life for everyone.
